News

Johnson & Johnson to acquire Abiomed | News from healthcareitnews.com

By November 8, 2022No Comments

The upfront payment for all shares of the company, which specializes in technologies for heart recovery, is valued at $16.6B.
 

News from healthcareitnews.com

Leave a Reply